Endometrial Cancer Trial, Recruiting NCT07077876 Sponsor: Fondazione Policlinico Universitario Agostino Gemelli IRCCS Condition: Endometrial Cancer
Back to Endometrial Cancer

Endometrial Cancer Trial, Recruiting

NCT07077876
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who are female and aged 18 years or older.
  • People who have been diagnosed through a tissue test with either endometrial adenocarcinoma (a type of uterine cancer) or atypical endometrial hyperplasia (abnormal thickening of the uterine lining).
  • People who had a procedure called hysteroscopic resection (a minimally invasive surgery to remove abnormal tissue from the uterus) performed by a specific surgeon at the CLASS Hysteroscopy Center.
  • People who received this less invasive treatment because a health condition made major surgery too risky for them.
  • People who have signed a consent form agreeing to take part in the study.

Who may not be able to join:

  • People who have other known reasons for being unable to conceive, beyond the conditions listed above.
  • People whose uterine cancer is of a type other than endometrioid (a specific subtype of uterine cancer) — (confirm with trial site if unsure which subtype applies).
  • People under 18 years of age.
  • People who have not agreed to participate by signing a consent form.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 28 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Ursula Catena, Fondazione Policlinico Universitario Agostino Gemelli IRCCS

Phone: +393382760021

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
20 June 2025
Est. completion
30 June 2025

Where this trial is recruiting

🇮🇹 Italy

Primary endpoints

Pregnancy Rate; Miscarriage Rate; Live Birth Rate

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov